GlassScriptPhysician profile
David W Krueger
NPI 1730294620
$9,785.77
in general payments reported to CMS, 2019-2025
62 companies · $2,194 in 2025
The $2,194 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,040 · 2020: $413 · 2021: $1,129 · 2022: $1,272 · 2023: $1,610 · 2024: $2,128 · 2025: $2,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,932.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,149.44 | 2019-2025 | Fintepla, Zilbrysq, Briviact |
| Alexion Pharmaceuticals, INC. | $748.04 | 2019-2025 | Ultomiris, Soliris |
| Abbvie INC. | $509.15 | 2021-2025 | |
| Lilly USA, LLC | $406.23 | 2019-2025 | Amyvid, Kisunla, Reyvow |
| Teva Pharmaceuticals USA, INC. | $387.63 | 2020-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ge Healthcare | $382.27 | 2019-2025 | |
| Eisai INC. | $350.89 | 2021-2025 | |
| Abbott Laboratories | $338.43 | 2023-2025 | Infinity |
| Neurocrine Biosciences, INC. | $329.26 | 2022-2025 | Ingrezza, Ongentys |
| Acadia Pharmaceuticals INC | $292.20 | 2019-2025 | Nuplazid |
| Neurelis, INC. | $289.72 | 2020-2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $270.56 | 2019-2025 | Rytary, Crexont |
| Amgen INC. | $262.74 | 2019-2025 | Uplizna |
| Merz Pharmaceuticals, LLC | $255.51 | 2021-2025 | Xeomin, Inbrija, Ampyra |
| Novartis Pharmaceuticals Corporation | $236.61 | 2019-2021 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Krueger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.